Cardiac Failure Review

Scope & Guideline

Innovating the future of heart health.

Introduction

Welcome to the Cardiac Failure Review information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cardiac Failure Review, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2057-7540
PublisherRADCLIFFE CARDIOLOGY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationCARD FAIL REV / Card. Fail. Rev.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIT F, BOURNE END BUSINESS PARK, BOURNE END, BUCKS SL8 5AS, ENGLAND

Aims and Scopes

The journal 'Cardiac Failure Review' is dedicated to advancing the understanding and management of heart failure through a comprehensive examination of its various aspects. The focus encompasses clinical, epidemiological, and therapeutic dimensions of heart failure, with an emphasis on innovative treatment strategies, diagnostic advancements, and patient-centered care.
  1. Heart Failure Management and Therapy:
    The journal emphasizes the latest developments in the management and therapeutic approaches to heart failure, including pharmacological treatments, device therapies, and patient education.
  2. Diagnostic Imaging and Biomarkers:
    A significant focus is placed on advancements in diagnostic imaging techniques and the identification of biomarkers that aid in the early detection, prognosis, and management of heart failure.
  3. Epidemiology and Public Health:
    Research published in the journal often addresses the epidemiological aspects of heart failure, including its global burden, demographic variations, and the impact of socioeconomic factors on patient outcomes.
  4. Multidisciplinary Approaches to Heart Failure Care:
    The journal highlights the importance of a multidisciplinary approach in heart failure management, integrating insights from cardiology, nursing, pharmacy, and public health.
  5. Emerging Therapies and Technologies:
    Innovations in treatment modalities, such as telemedicine and remote monitoring technologies, are explored to enhance patient management and outcomes.
The 'Cardiac Failure Review' has reflected emerging trends in heart failure research, highlighting new areas of focus that are gaining traction among researchers and clinicians. These trends indicate a shift towards more personalized, innovative, and comprehensive care models for heart failure patients.
  1. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF has surged, focusing on its unique challenges, treatment strategies, and the importance of this condition in the broader context of heart failure management.
  2. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote patient monitoring technologies has become increasingly prominent, particularly in light of the COVID-19 pandemic, emphasizing the need for innovative care solutions.
  3. Diversity and Health Disparities:
    There is a growing emphasis on understanding and addressing health disparities in heart failure care, particularly among minority populations, highlighting the importance of equitable healthcare access.
  4. Biomarkers and Personalized Medicine:
    The exploration of biomarkers for early detection and personalized treatment strategies is on the rise, reflecting a shift towards tailored therapy based on individual patient profiles.
  5. Multimodality Imaging:
    The use of multimodality imaging techniques to enhance diagnosis and treatment planning in heart failure is emerging as a critical theme, showcasing advancements in imaging technologies.

Declining or Waning

Over recent years, certain themes within the 'Cardiac Failure Review' have shown a decline in publication frequency, suggesting a shift in focus or a saturation of research in those areas. This decline may reflect evolving priorities in heart failure research or advancements that have rendered some topics less critical.
  1. Traditional Pharmacotherapy:
    While traditional pharmacotherapy for heart failure remains important, there has been a noticeable decline in articles focused on older classes of medications, as newer therapies and treatment strategies gain prominence.
  2. Basic Pathophysiological Studies:
    Research centered on basic pathophysiological mechanisms of heart failure has decreased, possibly due to a growing emphasis on clinical applications and translational research.
  3. Generalized Management Guidelines:
    Publications that reiterate general heart failure management guidelines without new insights or data have diminished, as the field moves towards more personalized and patient-specific treatment approaches.

Similar Journals

Netherlands Heart Journal

Leading the Way in Cardiovascular Research and Practice
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Hellenic Journal of Cardiology

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

Korean Circulation Journal

Elevating Cardiovascular Science Through Innovative Research.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Journal of Cardiovascular Echography

Empowering researchers with the latest in cardiology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2211-4122Frequency: 4 issues/year

Journal of Cardiovascular Echography, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a premier platform for global researchers, medical professionals, and students dedicated to the ever-evolving fields of cardiology and cardiovascular imaging. With the ISSN 2211-4122 and E-ISSN 2347-193X, this journal provides access to cutting-edge research from 2011 to 2024, offering insights into the latest advancements in echocardiographic techniques and their clinical applications. Despite its current classification in the Q3 quartile within both Cardiology and Cardiovascular Medicine as well as Radiology, Nuclear Medicine, and Imaging, it continues to make meaningful contributions to the academic community, ranking 234th in the Scopus category for Radiology and 278th in Cardiology. The Journal of Cardiovascular Echography is committed to furthering knowledge and fostering collaboration among researchers by sharing critical developments in the field, making it an essential resource for anyone looking to stay abreast of transformational changes in cardiovascular diagnostics.

CARDIOLOGY CLINICS

Exploring the forefront of cardiovascular medicine since 1983.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

IJC Heart & Vasculature

Shaping the Future of Cardiovascular Medicine Together
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

Arquivos Brasileiros de Cardiologia

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

PROGRESS IN PEDIATRIC CARDIOLOGY

Pioneering Discoveries in Heart Health for Children
Publisher: ELSEVIER IRELAND LTDISSN: 1058-9813Frequency: 4 issues/year

PROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.

CURRENT OPINION IN CARDIOLOGY

Exploring the forefront of cardiovascular innovation.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

TEXAS HEART INSTITUTE JOURNAL

Advancing Cardiovascular Knowledge, One Heartbeat at a Time.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.